9-氨基-N-[2-(二甲基氨基)乙基]-4-吖啶甲酰胺 | 89459-43-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 9-氨基-N-[2-(二甲基氨基)乙基]-4-吖啶甲酰胺
• 英文名称: N-<2-(dimethylamino)ethyl>-9-aminoacridine-4-carboxamide
• 英文别名: N-[2-(N-dimethylamino)ethyl]-9-aminoacridine-4-carboxamide；9-amino-N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide；N-[(2-dimethylamino)ethyl]-9-aminoacridine-4-carboxamide；N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide；9-Amino-n-[2-(dimethylamino)ethyl]-4-acridinecarboxamide；9-amino-N-[2-(dimethylamino)ethyl]acridine-4-carboxamide
• CAS: 89459-43-8
• 化学式: C₁₈H₂₀N₄O
• 分子量: 308.383
• InChiKey: YLGMVQJPGUHTRO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  71.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  9-氯-N-[2-(二甲氨基)乙基]吖啶-4-甲酰胺 在 氨 作用下， 以 various solvent(s) 为溶剂， 生成 9-氨基-N-[2-(二甲基氨基)乙基]-4-吖啶甲酰胺
  参考文献：
  名称：

  潜在的抗肿瘤药。43.新型抗肿瘤药二元9-氨基ac啶-4-羧酰胺的合成及生物活性。

  摘要：

  报道了新型抗肿瘤剂N- [2-（二烷基氨基）乙基] -9-氨基ac啶-4-羧酰胺的代表的合成和生物学活性。这类成员是稳定的并且非常易溶于水，具有高水平的体外和体内抗肿瘤活性。这些化合物通过插入与双链DNA紧密结合，但对抗肿瘤活性的要求更为严格。它们主要取决于两个阳离子中心的分离距离，位置和pKa值。对于体内活性，对于C-9 a啶位置附近的亲脂性但不存在亲水性基团以及侧链阳离子部分上的亲脂性和亲水性基团存在显着的体积耐受性。侧链阳离子中心pKa的显着减弱消除了活性，

  DOI：

  10.1021/jm00377a017

文献信息

• Bisintercalating Threading Diacridines:  Relationships between DNA Binding, Cytotoxicity, and Cell Cycle Arrest
  作者：Laurence P. G. Wakelin、Xianyong Bu、Alexandra Eleftheriou、Alpesh Parmar、Charbel Hayek、Bernard W. Stewart

  DOI：10.1021/jm030253d

  日期：2003.12.1

  synthesized a series of bis(9-aminoacridine-4-carboxamides) linked via the 9-position with neutral flexible alkyl chains, charged flexible polyamine chains, and a semirigid charged piperazine-containing chain. The carboxamide side chains comprise N,N-dimethylaminoethyl and ethylmorpholino groups. The compounds are designed to bisintercalate into DNA by a threading mode, in which the side chains are intended to

  我们已经合成了一系列经由9位与中性柔性烷基链，带电柔性多胺链和半刚性带电含哌嗪的双（9-氨基ac啶-4-甲酰胺）连接。羧酰胺侧链包含N，N-二甲基氨基乙基和乙基吗啉代基团。这些化合物设计为通过穿线方式双插入DNA，在这种方式中，侧链旨在与主沟中鸟嘌呤的O6 / N7原子形成氢键接触，连接子位于次沟中。通过这种方式，我们预计它们将与DNA缓慢解离，并且由于模板抑制转录而具有细胞毒性。二聚体以26至46度的螺旋展开角去除并逆转了封闭的环状DNA的超螺旋，证实了在所有情况下的双功能嵌入，并且代表性成员的DNA复合物的解离速度比简单的氨基slowly啶要慢许多数量级。确定了对人类白血病CCRF-CEM细胞的细胞毒性，最具活性的药物的IC（50）值为35-50 nM，范围超过20倍，而二甲基氨基乙基和乙基吗啉代系列在本质上都没有毒性。与已建立的转录抑制剂一样，吗啉代系列（除一个例外）对随机划分的CC
• Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides
  作者：Brian D. Palmer、Gordon W. Rewcastle、Graham J. Atwell、Bruce C. Baguley、William A. Denny

  DOI：10.1021/jm00399a003

  日期：1988.4

  thioxanthenone, anthraquinone, pyridoquinazoline, dibenzodioxin, thianthrene, phenothiazine, phenoxazine, dibenzofuran, carbazole, and pyridoindole) of the general class of N-[2-(dimethylamino)ethyl] linear tricyclic carboxamides. Only the compounds containing coplanar chromophores intercalated DNA. There is an absolute requirement for an oxygen or aromatic nitrogen (possibly as hydrogen-bond acceptors) peri to

  报道了一般结构的许多不同实例（ac啶，吩嗪，蒽，a啶、,吨酮，噻吨酮，蒽醌，吡啶并喹唑啉，二苯并二恶英，噻吨，吩噻嗪，吩恶嗪，二苯并呋喃，咔唑和吡啶基吲哚的结构-抗肿瘤活性关系。 N- [2-（二甲基氨基）乙基]线性三环羧酰胺。仅包含共面发色团的化合物插入DNA。绝对需要羧酰胺周围的氧或芳族氮（可能是氢键受体），以及用于生物活性的平面环几何形状。除了进一步描述这类化合物的药效基团的性质外，该工作还确定了二苯并[1,4]二恶英是一种具有体内抗肿瘤活性的新型DNA嵌入发色团。
• COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES
  申请人：Johansen Lisa M.

  公开号：US20100009970A1

  公开（公告）日：2010-01-14

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

  本发明涉及用于治疗病毒性疾病的组合物、方法和试剂盒。在某些实施方式中，病毒性疾病是由单链RNA病毒、黄病毒科病毒或肝病毒引起的。在特定实施方式中，病毒性疾病是病毒性肝炎（例如甲型肝炎、乙型肝炎、丙型肝炎、丁型肝炎、戊型肝炎），药剂或药剂组合包括舍曲林、舍曲林类似物、UK-416244或UK-416244类似物。还包括用于鉴定可用于治疗病毒性疾病的新化合物的筛选方法。
• Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide
  作者：Gordon W. Rewcastle、Graham J. Atwell、David Chambers、Bruce C. Baguley、William A. Denny

  DOI：10.1021/jm00154a008

  日期：1986.4

  A series of monosubstituted derivatives of the new antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide has been prepared, bearing methyl, methoxy, and chloro groups at available acridine positions. The physicochemical properties and antitumor activity of these compounds varied more with the position than with the nature of the substituent groups. The highest levels of both in vitro and in vivo antileukemic activity were shown by 5-substituted derivatives, while 7- and 8-substituted derivatives possessed the highest selectivity toward the HCT-8 human colon carcinoma line compared to the L1210 mouse leukemia line in vitro.
• DNA threading agents: effect of sidechain bulk on DNA binding and cytotoxicity of 9-anilinoacridine-4-carboxamides
  作者：Mark Searcey、P. Noel Martin、Nicola M. Howarth、Bernie Madden、Laurence P.G. Wakelin

  DOI：10.1016/0960-894x(96)00325-3

  日期：1996.8

  A series of 9-anilinoacridine-4-carboxamides with cycloalkyl sidechains has been synthesised to study the effect of sidechain bulk on the DNA binding properties and biological activity of these potential threading intercalators. With sidechains larger than cyclohexane the pKa of the acridine is exceptionally low, so that DNA binding is restricted to pHs below 5. The compounds are cytotoxic to human colon carcinoma cells in the mu M range irrespective of their ability to bind to DNA. Copyright (C) 1996 Elsevier Science Ltd